CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
CIBMTR Reporting Implementation Guide
0.1.8 - Trial Use 1
This page is part of the CIBMTR Reporting Implementation Guide (v0.1.8: Release Draft) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.nmdp.org/ig/cibmtr-reporting/ValueSet/med-cytarabine-vs | Version: 0.1.8 | |||
| Draft as of 2025-02-18 | Computable Name: RxNormCytarabineVS | |||
RxNorm codes for Cytarabine
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet med-cytarabine-vs
http://www.nlm.nih.gov/research/umls/rxnorm| Code | Display |
| 151319 | Alexan |
| 3041 | cytarabine |
| 151577 | Cytosar |
| 220177 | Tarabine PFS |
| 196337 | DepoCyt |
| 1942744 | Vyxeos |
| 1175506 | Alexan Injectable Product |
| 2285813 | cytarabine / daunorubicin Injectable Product |
| 2285807 | cytarabine / daunorubicin Injection |
| 331779 | cytarabine 100 MG/ML |
| 332422 | cytarabine 20 MG/ML |
| 564102 | cytarabine 20 MG/ML [Alexan] |
| 564515 | cytarabine 20 MG/ML [Cytosar] |
| 572983 | cytarabine 20 MG/ML [Tarabine PFS] |
| 105580 | cytarabine 20 MG/ML Injectable Solution [Alexan] |
| 108359 | cytarabine 20 MG/ML Injectable Solution [Cytosar] |
| 213044 | cytarabine 20 MG/ML Injectable Solution [Tarabine PFS] |
| 333668 | cytarabine 50 MG/ML |
| 564516 | cytarabine 50 MG/ML [Cytosar] |
| 108360 | cytarabine 50 MG/ML Injectable Solution [Cytosar] |
| 1151483 | cytarabine Injectable Product |
| 371676 | cytarabine Injectable Solution |
| 362596 | cytarabine Injectable Solution [Alexan] |
| 363023 | cytarabine Injectable Solution [Cytosar] |
| 362991 | cytarabine Injectable Solution [Tarabine PFS] |
| 544939 | cytarabine Injectable Suspension |
| 1731354 | cytarabine Injection |
| 968805 | cytarabine liposome 10 MG/ML |
| 1942738 | cytarabine liposome 100 MG |
| 1174486 | Cytosar Injectable Product |
| 1179037 | Tarabine PFS Injectable Product |
| 2017575 | cytarabine / daunorubicin |
Generated Narrative: ValueSet
Expansion from tx.fhir.org based on codesystem RxNorm version09032024
This value set contains 32 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |